GitLab Inc (GTLB) stock received an upgrade to Buy from Hold by Needham analyst Mike Cikos, who cited the company’s expanding product offerings and strong enterprise sales as key drivers for growth. Cikos expects increased adoption of GitLab’s Ultimate tier, driven by its compliance and security features, and predicts that the company could exceed revenue estimates in the coming quarters.
Needham analyst Charles Shi remains bullish on Taiwan Semiconductor Manufacturing Company (TSM), raising his price target to $225 due to the company’s strong third-quarter performance and positive outlook for 2025. Shi expects revenue to reach $110 billion in 2025, driven by volume growth and margin improvement, leading to a potential boost in free cash flow and dividends.
Needham analyst Kyle Peterson initiated coverage on Axos Financial with a ‘Buy’ rating and a price target of $82.00, highlighting the company’s digital-first strategy, strong profitability, and potential for growth. Peterson believes Axos Financial’s unique approach and corporate culture position it for continued success in the banking industry.
Needham analyst Laura Martin reaffirms her Buy rating for Disney, citing strong direct-to-consumer (DTC) growth, strategic partnerships, and a robust content library. Martin expects Disney to reach DTC breakeven in 2024 and projects significant subscriber growth, driven by new deals with Charter Communications and the success of Disney+ content. She also highlights Disney’s strategic investments in areas like gaming (Epic Games) and its focus on building capacity for future growth in its parks. While revising her estimates for the fourth quarter, Martin remains bullish on Disney’s long-term prospects.
Needham analyst John Todaro initiated coverage on TeraWulf Inc (WULF) with a Buy rating and a $6 price target, citing the company’s potential in the high-margin High-Performance Computing (HPC) market. Todaro believes TeraWulf is well-positioned to capitalize on this growing market with its existing data center infrastructure and plans to bring a 100MW+ site online for HPC. He expects TeraWulf to generate significant revenue from HPC in the coming years, leading to attractive margins.
Needham analyst initiated coverage on TransMedics Group (TMDX), a medical technology company revolutionizing organ transplantation with its Organ Care System (OCS). The analyst sees significant growth potential in the underpenetrated organ transplant market, driven by the company’s National OCS Program (NOP) and innovative OCS technology. The analyst predicts TransMedics will become profitable in 2024 and sees rapid improvement in operating margin, EPS, and cash flow in 2025-2026.
